FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 18:37:02 10/05/2024 BST | ||
| 2.22 EUR | +0.91% |
|
| Current month | -39.67% | ||
| 1 month | -45.05% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 2.22 | +0.91% | 0 |
| 09/05/24 | 2.2 | -8.33% | 0 |
| 08/05/24 | 2.4 | -4.00% | 0 |
| 07/05/24 | 2.5 | -0.79% | 0 |
| 06/05/24 | 2.52 | +15.60% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 10, 2024 at 06:37 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UL67NV |
| ISIN | DE000UL67NV8 |
| Date issued | 10/08/2023 |
| Strike | 417.1 $ |
| Maturity | Unlimited |
| Parity | 43.33 : 1 |
| Emission price | 5.2 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.94 € |
|---|---|
| Lowest since issue | 1.92 € |
| Spread | 0.05 € |
| Spread % | 2.16% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat
